abbvie glp-1 receptor agonists weight management diabetes treatments Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Agonists: A Multidisciplinary Expert Consensus GLP-1 agonists for weight loss:

By causing more weight loss and lowering inflammation, blood sugar, cholesterol, and liver fat , these medicines can reduce risks for heart disease, diabetes, and fatty liver disease

OCULAR ADVERSE EFFECTS Other cancers Recent investigations have highlighted the association between various neoplasms, such as thyroid, breast, and cholangiocarcinoma, and GLP-1 RAs [105-107]

Finally, obese mice lost weight more effectively when dexamethasone and GLP- 1 were conjugated than when GLP- 1 was used alone [142]

The greater weight loss achieved with semaglutide may contribute to its enhanced hepatic benefits

doi: 10.1152/ajpendo.00330.2023 [DOI] [PMC free article] [PubMed] [Google Scholar] 170

That slowing effect is well established and explains why gastrointestinal symptoms such as nausea, constipation and altered bowel habits are among the most common side effects